Tapewire

Nasdaq · USD

INVZ

Innoviz Technologies Ltd.

Export transactions ↓
Tapewire entity
6753
SEC CIK
0001835654
Parsed reports
29

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 04, 2026 Filed Aug 5, 2026 20:23 UTC GrantOrdinary Shares 90,162 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-003871 · ownership.xml · nonDerivative · entry 1

Har Even Yoav · CIK 0002145803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,162

F1 · shares: Represents 90,162 Restricted Share Units (RSUs) granted on August 4, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F1 · balance_after: Represents 90,162 Restricted Share Units (RSUs) granted on August 4, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:21 UTC
Luski IdoChief Operating Officer
GrantShare Option · Derivative 69,296 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001178913-26-003869 · ownership.xml · derivative · entry 2

Luski Ido · CIK 0002087694 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,296

Underlying: Ordinary Shares · 69,296 shares

Expires 2033-08-04

F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:21 UTC
Luski IdoChief Operating Officer
GrantOrdinary Shares 64,688 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-003869 · ownership.xml · nonDerivative · entry 1

Luski Ido · CIK 0002087694 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,701

F1 · shares: Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 230,260 ordinary shares issuable upon vesting of RSUs; of which (a) 1,949 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,304 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 9,803 RSUs granted February 27, 2024, with 1,956 vesting quarterly through 2027 and 7,847 vesting quarterly through 2028; (d) 19,089 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,343 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 66,252 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 46,832 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 64,688 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:19 UTC
Cegla Eldar MordechayChief Financial Officer
GrantShare Option · Derivative 78,416 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001178913-26-003867 · ownership.xml · derivative · entry 2

Cegla Eldar Mordechay · CIK 0001964080 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,416

Underlying: Ordinary Shares · 78,416 shares

Expires 2033-08-04

F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:19 UTC
Cegla Eldar MordechayChief Financial Officer
GrantOrdinary Shares 73,184 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-003867 · ownership.xml · nonDerivative · entry 1

Cegla Eldar Mordechay · CIK 0001964080 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 537,237

F1 · shares: Represents 73,184 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 234,628 ordinary shares issuable upon vesting of RSUs; of which (a) 2,607 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 11,104 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 13,109 RSUs granted February 27, 2024, with 2,616 vesting quarterly through 2027 and 10,493 vesting quarterly through 2028; (d) 25,524 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 15,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,016 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 73,184 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:16 UTC
Hofstetter Elad BenChief Business Officer
GrantShare Option · Derivative 57,968 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001178913-26-003865 · ownership.xml · derivative · entry 2

Hofstetter Elad Ben · CIK 0002030148 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,968

Underlying: Ordinary Shares · 57,968 shares

Expires 2033-08-04

F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:16 UTC
Hofstetter Elad BenChief Business Officer
GrantOrdinary Shares 54,112 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-003865 · ownership.xml · nonDerivative · entry 1

Hofstetter Elad Ben · CIK 0002030148 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,256

F1 · shares: Represents 54,112 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 176,964 ordinary shares issuable upon vesting of RSUs; of which (a) 1,782 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 7,592 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 10,454 RSUs granted February 27, 2024, with 1,788 vesting quarterly through 2027 and 8,666 vesting quarterly through 2028; (d) 21,087 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 11,341 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 30,804 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 54,112 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:13 UTC
Moscovici Avishay BenChief R&D Officer
GrantShare Option · Derivative 71,072 $0.00 Strike: $0.42 $0.00
Disclosure

SEC source: 0001178913-26-003863 · ownership.xml · derivative · entry 2

Moscovici Avishay Ben · CIK 0002030150 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,072

Underlying: Ordinary Shares · 71,072 shares

Expires 2033-08-04

F4 · derivative.exercise_date: Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Read SEC document
August 04, 2026 Filed Aug 5, 2026 20:13 UTC
Moscovici Avishay BenChief R&D Officer
GrantOrdinary Shares 66,336 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-003863 · ownership.xml · nonDerivative · entry 1

Moscovici Avishay Ben · CIK 0002030150 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 397,001

F1 · shares: Represents 66,336 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 213,724 ordinary shares issuable upon vesting of RSUs; of which (a) 2,005 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,540 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 12,471 RSUs granted February 27, 2024, with 2,013 vesting quarterly through 2027 and 10,458 vesting quarterly through 2028; (d) 25,452 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,684 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 37,188 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 48,048 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 66,336 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

F3 · balance_after: Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 10:01 UTC
Keilaf Omer DavidDirector · Chief Executive Officer
OtherShare Option · Derivative 25,641 $0.00 Strike: $4.03 $0.00
Disclosure

SEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 5

Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,575

Underlying: Ordinary Shares · 25,641 shares

Expires 2030-08-01

F6 · security: Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.

F6 · derivative.exercise_date: Share options granted on August 1, 2023. The balance reported includes 54,945 vested options and 36,630 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 10:01 UTC
Keilaf Omer DavidDirector · Chief Executive Officer
OtherShare Option · Derivative 29,240 $0.00 Strike: $5.23 $0.00
Disclosure

SEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 4

Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,328

Underlying: Ordinary Shares · 29,240 shares

Expires 2029-08-09

F5 · security: Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.

F5 · derivative.exercise_date: Share options granted on August 9, 2022. The balance reported includes 58,480 vested options and 5,848 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 10:01 UTC
Keilaf Omer DavidDirector · Chief Executive Officer
OtherShare Option · Derivative 342,408 $0.00 Strike: $9.92 $0.00
Disclosure

SEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 3

Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,408

Underlying: Ordinary Shares · 342,408 shares

Expires 2028-05-12

F4 · security: Immediately exercisable.

F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 10:01 UTC
Keilaf Omer DavidDirector · Chief Executive Officer
OtherShare Option · Derivative 510,222 $0.00 Strike: $11.50 $0.00
Disclosure

SEC source: 0001178913-26-003450 · zk2635665.xml · derivative · entry 2

Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 510,222

Underlying: Ordinary Shares · 510,222 shares

Expires 2028-05-12

F4 · security: Immediately exercisable.

F1 · shares: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 10:01 UTC
Keilaf Omer DavidDirector · Chief Executive Officer
OtherOrdinary Shares 679,400 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-003450 · zk2635665.xml · nonDerivative · entry 1

Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,826,531

F1 · balance_after: Represents a transfer of an aggregate of 679,400 ordinary shares and options to purchase an aggregate of 907,511 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, for no consideration, pursuant to a divorce settlement. The transferred ordinary shares consist of shares previously issued to the Reporting Person upon vesting and settlement of restricted share units, and the transferred options are reported in Table II.

F2 · balance_after: The amount includes 916,552 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 7,798 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 62,978 RSUs granted February 27, 2024, with 10,674 vesting quarterly through 2027 and 52,304 vesting quarterly through 2028; (d) 54,531 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 75,251 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 562,500 RSUs granted May 26, 2025, vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

F3 · balance_after: No consideration was paid in connection with the transfer. No exercise price is applicable.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:14 UTC GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002723 · ownership.xml · nonDerivative · entry 1

Jacoby Stefan · CIK 0001583553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,994

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 181,326 ordinary shares.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:05 UTC GrantOrdinary Shares 265,602 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002713 · ownership.xml · nonDerivative · entry 1

Steimberg Amichai · CIK 0001771362 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 989,336

F1 · shares: Represents 265,602 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 723,734 ordinary shares.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:13 UTC GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002721 · ownership.xml · nonDerivative · entry 1

Maor Shenaar Ronit · CIK 0001965194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,997

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 234,329 ordinary shares.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:11 UTC
Stav OritDirector
GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002719 · ownership.xml · nonDerivative · entry 1

Stav Orit · CIK 0001965230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,997

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 234,329 ordinary shares.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:09 UTC GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002717 · ownership.xml · nonDerivative · entry 1

Sheridan James J. III · CIK 0001891058 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 427,397

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 234,329 ordinary shares held directly by Mr. Sheridan, and 82,400 ordinary shares held by Perception Capital Partners, LLC. Mr. Sheridan is a director appointed by Perception Capital Partners, LLC and may be deemed to be the beneficial owner of the securities held by Perception Capital Partners, LLC.

F2 · ownership.direct: Includes 234,329 ordinary shares held directly by Mr. Sheridan, and 82,400 ordinary shares held by Perception Capital Partners, LLC. Mr. Sheridan is a director appointed by Perception Capital Partners, LLC and may be deemed to be the beneficial owner of the securities held by Perception Capital Partners, LLC.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:07 UTC GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002715 · ownership.xml · nonDerivative · entry 1

Falk Dan Michael · CIK 0001966097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,997

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 234,329 ordinary shares.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:03 UTC GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002711 · ownership.xml · nonDerivative · entry 1

Von Witzleben Alexander Reymar Karl-Wilhelm · CIK 0002023671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,768

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 186,100 ordinary shares.

Read SEC document
May 13, 2026 Filed May 15, 2026 10:01 UTC GrantOrdinary Shares 110,668 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002709 · ownership.xml · nonDerivative · entry 1

Aharon Aharon · CIK 0001966840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,997

F1 · shares: Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

F2 · balance_after: Includes 234,329 ordinary shares.

Read SEC document
April 30, 2026 Filed May 4, 2026 12:49 UTC
Keilaf Omer DavidDirector · Chief Executive Officer
OtherOrdinary Shares 723,019 $0.00 $0.00
Disclosure

SEC source: 0001178913-26-002357 · zk2635194.xml · nonDerivative · entry 1

Keilaf Omer David · CIK 0001964231 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,505,931

F1 · balance_after: Represents a transfer of 723,019 ordinary shares from the Reporting Person to his former spouse, Ms. Gali Moscovici, pursuant to a divorce settlement.

F2 · balance_after: The amount includes 1,135,780 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 15,596 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 36,630 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 74,008 RSUs granted February 27, 2024, with 14,232 vesting quarterly through 2027 and 59,776 vesting quarterly through 2028; (d) 60,590 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 82,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 750,000 RSUs granted May 26, 2025, one-fourth vesting on May 26, 2026, remainder vesting quarterly through 2029; and (g) 116,864 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

F3 · balance_after: No exercise price is applicable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.